Skip to product information
1 of 1

Boehringer Ingelheim

Express FP 10 HB

Express FP 10 HB

Regular price $10.79 USD
Regular price Sale price $10.79 USD
Sale Sold out
Size

Boehringer Ingelheim Express FP 10 HB is a modified live vaccine for use in healthy cows and heifers prior to breeding. Aids in the prevention of infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD) Types 1 and 2, parainfluenza 3 (PI3), bovine respiratory syncytial virus (BRSV), and 5 common strains of Leptospirosis (Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona). Pregnant cows or calves nursing pregnant cows can be vaccinated with Express FP 10 HB provided the cows were vaccinated pre-breeding, according to label instructions, with any Express FP vaccine within the past 12 months.

Research has shown the duration of immunity against IBR-induced abortion and against BVD Types 1 and 2, including persistently infected calves, is at least 12 months. Also shown to be effective against urinary shedding of L. borgpetersenii serovar hardjo (type Hardjo-bovis). Vaccinated animals subsequently exposed to hardjo-bovi Lepto strain have been shown to clear renal infections within 8 weeks of exposure.

For prevention of persistently infected calves caused by BVD virus types 1 and 2 and as an aid in the prevention of abortion due to IBR virus and urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Also used as an aid in the prevention of respiratory disease caused by IBR virus, BVD virus types 1 and 2 and BRSV and as an aid in the reduction of respiratory disease caused by PI3.As an aid in reduction of leptospirosis caused by 5-way Lepto. A 12-month duration of immunity has been demonstrated against IBR-induced abortion and against disease, including persistently infected calves, caused by BVD types 1 and 2. In addition, vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

Dosage: Swirl bottle before usage. 2 mL SQ or IM. If initial vaccination, repeat with any Express vaccine containing Leptospira and BRSV modified live virus (MLV) in 14-28 days. Calves vaccinated before 6 months of age should be revaccinated at 6 months.

Manufacturer and/or Label Information

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone: 800-325-9167
Customer Service: 800-243-0127
Fax: 816-236-2717
Website: www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
EXPRESS® FP 10 HB

Boehringer Ingelheim Animal Health

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Modified Live Virus

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

BEEF & DAIRY CATTLE

Indications: This product has been shown to be effective for the vaccination of healthy cattle, including pregnant cows, against reproductive and respiratory disease due to infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea types 1 and 2 (BVD1 & BVD2); against respiratory disease due to parainfluenza 3 (PI3) and bovine respiratory syncytial virus (BRSV); and against Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity against IBR-induced abortion and against BVD1 & BVD2, including persistently infected calves, is at least 12 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

The product has also been shown to be effective against abortion due to IBR; against persistently infected calves due to BVD1 & BVD2; and against urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. This vaccine may be used in pregnant cows or calves nursing pregnant cows provided the cows were vaccinated pre-breeding, according to label instructions, with any Express FP vaccine within the past 12 months.

Composition: The amber glass vial contains IBR, BVD1 (Singer 1a cytopathic), BVD2 (296 cytopathic), PI3, and BRSV modified live viruses (MLV). The plastic vial contains the Leptospira organisms listed, in an adjuvant system. Neomycin and thimerosal added as preservatives.

Directions and dosage: Mix the accompanying bottle of diluent. Rehydrate the vaccine by aseptically adding the diluent to the vaccine vial. Mix well and use immediately. Using aseptic technique, inject 2 mL subcutaneously or intramuscularly. For cows or heifers, vaccinate at or about 4 weeks prior to breeding. If using subcutaneous route, inject in front of the shoulder and midway of the neck, away from the suprascapular lymph node. If initial vaccination, repeat with any Express vaccine containing Leptospira and BRSV MLV in 14 to 28 days. Contact your veterinarian or the manufacturer for information on revaccination frequency.

Precautions: Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with

other products, except as specified on the label. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Injection site swelling may occur. Stressed cattle should not be vaccinated. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician. Inactivate unused contents before disposal.

Fetal health risks associated with vaccination of pregnant animals with this vaccine cannot be unequivocally determined by clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian.

No vaccine can be expected to have 100% efficacy under all conditions. A small number of calves persistently infected with BVD may have a devastating effect on herd health.

Note: It is possible that healthy-appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. In view of these findings and suggested causes, BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy, immunocompetent, unstressed cattle.

Express® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/4469.24

5 Doses/Rehydrate with 10 mL

This package contains one 5 dose vial of MLV vaccine and one 10 mL vial of bacterin diluent.

127908-05

10 Doses/Rehydrate with 20 mL

This package contains one 10 dose vial of MLV vaccine and one 20 mL vial of bacterin diluent.

127901-07

50 Doses/Rehydrate with 100 mL

This package contains one 50 dose vial of MLV vaccine and one 100 mL vial of bacterin diluent.

127902-07

CPN: 1028140.5

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details